Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Notch Signaling in Breast Cancer: A Role in Drug Resistance
McKenna BeLow, Clodia Osipo
Cells (2020) Vol. 9, Iss. 10, pp. 2204-2204
Open Access | Times Cited: 87

Showing 1-25 of 87 citing articles:

The role of m6A methylation in therapy resistance in cancer
Hengzhao Zhuang, Bo Yu, Dan Tao, et al.
Molecular Cancer (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 83
PMN-MDSCs modulated by CCL20 from cancer cells promoted breast cancer cell stemness through CXCL2-CXCR2 pathway
Rui Zhang, Mengxue Dong, Juchuanli Tu, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 63
A review on epidermal growth factor receptor's role in breast and non-small cell lung cancer
Vetriselvan Subramaniyan, Shivkanya Fuloria, Gaurav Gupta, et al.
Chemico-Biological Interactions (2021) Vol. 351, pp. 109735-109735
Closed Access | Times Cited: 72
Natural medicinal compounds target signal transduction pathways to overcome ABC drug efflux transporter-mediated multidrug resistance in cancer
Pradhapsingh Bharathiraja, Priya Yadav, Andaleeb Sajid, et al.
Drug Resistance Updates (2023) Vol. 71, pp. 101004-101004
Open Access | Times Cited: 38
Exploration of the Use of Natural Compounds in Combination with Chemotherapy Drugs for Tumor Treatment
Jian Wu, Yunheng Li, Qiaojun He, et al.
Molecules (2023) Vol. 28, Iss. 3, pp. 1022-1022
Open Access | Times Cited: 34
Deciphering the Role of Cancer Stem Cells: Drivers of Tumor Evolution, Therapeutic Resistance, and Precision Medicine Strategies
Mohamed El‐Tanani, Syed Arman Rabbani, Shakta Mani Satyam, et al.
Cancers (2025) Vol. 17, Iss. 3, pp. 382-382
Open Access | Times Cited: 1
Potentiating Therapeutic Effects of Epidermal Growth Factor Receptor Inhibition in Triple-Negative Breast Cancer
Kyu Sic You, Yong Weon Yi, Jeonghee Cho, et al.
Pharmaceuticals (2021) Vol. 14, Iss. 6, pp. 589-589
Open Access | Times Cited: 46
Notch signaling pathway: a comprehensive prognostic and gene expression profile analysis in breast cancer
Hassan Yousefi, Afshin Bahramy, Narges Zafari, et al.
BMC Cancer (2022) Vol. 22, Iss. 1
Open Access | Times Cited: 33
Cancer Stem Cells and the Tumor Microenvironment: Targeting the Critical Crosstalk through Nanocarrier Systems
Aadya Nayak, Neerada Meenakshi Warrier, Praveen Kumar
Stem Cell Reviews and Reports (2022) Vol. 18, Iss. 7, pp. 2209-2233
Open Access | Times Cited: 29
Natural Products in Preventing Tumor Drug Resistance and Related Signaling Pathways
Chuansheng Yang, Zhikai Mai, Can Liu, et al.
Molecules (2022) Vol. 27, Iss. 11, pp. 3513-3513
Open Access | Times Cited: 28
Notch Signaling in Breast Tumor Microenvironment as Mediator of Drug Resistance
Adele Chimento, Maria D’Amico, Vincenzo Pezzi, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 11, pp. 6296-6296
Open Access | Times Cited: 26
Protein Kinase C (PKC) Isozymes as Diagnostic and Prognostic Biomarkers and Therapeutic Targets for Cancer
Takahito Kawano, Junichi Inokuchi, Masatoshi Eto, et al.
Cancers (2022) Vol. 14, Iss. 21, pp. 5425-5425
Open Access | Times Cited: 25
Emerging treatment strategies for metastatic triple-negative breast cancer
Laura A. Huppert, Özge Gümüşay, Hope S. Rugo
Therapeutic Advances in Medical Oncology (2022) Vol. 14
Open Access | Times Cited: 24
Inhibition of γ-secretase/Notch pathway as a potential therapy for reversing cancer drug resistance
Mei Feng, Ramesh Kumar Santhanam, Huan Xing, et al.
Biochemical Pharmacology (2023) Vol. 220, pp. 115991-115991
Closed Access | Times Cited: 14
Notch signaling pathway: a new target for neuropathic pain therapy
Yan Zhang, Tingting Wang, Sanlan Wu, et al.
The Journal of Headache and Pain (2023) Vol. 24, Iss. 1
Open Access | Times Cited: 13
Peiminine triggers ferroptosis to inhibit breast cancer growth through triggering Nrf2 signaling
Nian Yi, Li Wang, Zhongjun Jiang, et al.
Tissue and Cell (2024) Vol. 87, pp. 102323-102323
Closed Access | Times Cited: 5
New curcumin derivative induces ferroptosis in MCF-7 cells through activating SLC7A11/GPX4 axis
Zhiwen Wu, Guoqiang Zhang, Yifan Shang, et al.
Bioorganic & Medicinal Chemistry (2025), pp. 118078-118078
Closed Access
Divide and Conquer—Targeted Therapy for Triple-Negative Breast Cancer
Milica Nedeljković, Ana Vuletić, Katarina Mirjačić Martinović
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 4, pp. 1396-1396
Open Access
Innovative approaches in breast cancer therapy: repurposing nanocarriers for enhanced outcomes
Sana Naaz Siddiqui, Md. Faheem Haider, M.A. Rahman
Naunyn-Schmiedeberg s Archives of Pharmacology (2025)
Closed Access
Celastrol and Triptolide Suppress Stemness in Triple Negative Breast Cancer: Notch as a Therapeutic Target for Stem Cells
Prabhu Ramamoorthy, Prasad Dandawate, Roy A. Jensen, et al.
Biomedicines (2021) Vol. 9, Iss. 5, pp. 482-482
Open Access | Times Cited: 30
Advances of nanotechnology applied to cancer stem cells
Miao Yue, Ting Guo, Dengyun Nie, et al.
World Journal of Stem Cells (2023) Vol. 15, Iss. 6, pp. 514-529
Open Access | Times Cited: 12
Targeting drug‐tolerant cells: A promising strategy for overcoming acquired drug resistance in cancer cells
Xiao-Hai Song, Lan Yang, Xiuli Zheng, et al.
MedComm (2023) Vol. 4, Iss. 5
Open Access | Times Cited: 11
Identification of a Notch transcriptomic signature for breast cancer
Eike-Benjamin Braune, Felix Geist, Xiaojia Tang, et al.
Breast Cancer Research (2024) Vol. 26, Iss. 1
Open Access | Times Cited: 4
Integrins in Health and Disease—Suitable Targets for Treatment?
Tanja Klaus, Christoph Hieber, Matthias Bros, et al.
Cells (2024) Vol. 13, Iss. 3, pp. 212-212
Open Access | Times Cited: 4
The impact of epithelial-mesenchymal transition (EMT) induced by metabolic processes and intracellular signaling pathways on chemo-resistance, metastasis, and recurrence in solid tumors
Mahsa Liaghat, Saeid Ferdousmakan, Seyedeh Haniyeh Mortazavi, et al.
Cell Communication and Signaling (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 4
Page 1 - Next Page

Scroll to top